DGCR8 Inhibitors

Chemical inhibitors of DGCR8 can impact its function in various ways, each related to the protein's role in the microprocessor complex and miRNA maturation. Mithramycin A, for instance, inhibits RNA polymerase II, leading to a reduced transcription of the molecules that DGCR8 processes, thereby indirectly diminishing its functional role. Enoxacin, by binding to TRBP, can interfere with the formation of the Dicer-TRBP complex which is crucial for DGCR8's function in pri-miRNA processing. Aurintricarboxylic Acid takes a different approach, inhibiting RNAse and potentially causing an accumulation of pri-miRNA substrates that DGCR8 processes, which could saturate and thus inhibit DGCR8's activity. Similarly, Quercetin targets phosphorylation events, pivotal for DGCR8's activity, to prevent the proper assembly and function of the microprocessor complex.

Continuing along these lines, 5-Azacytidine gets incorporated into RNA and DNA, which can alter the RNA binding or processing functions of DGCR8. Bisphenol A is known to disrupt nucleic acid interactions and could inhibit the binding of DGCR8 to pri-miRNAs, impacting its processing activity. Chloroquine raises endosomal pH, potentially altering mRNA processing and maturation, which can impact DGCR8's interaction with pri-miRNA substrates. Plumbagin, Actinomycin D, and Triptolide all inhibit nucleic acid synthesis, which could result in a reduced availability of pri-miRNA molecules, thereby indirectly inhibiting DGCR8's processing capabilities. Rocaglamide, by inhibiting eIF4A, can disrupt the translation of pri-miRNAs, affecting the substrate profile that DGCR8 works on. Finally, Oxymatrine impacts DGCR8 by altering the expression of miRNAs, thus affecting the range of substrates available for DGCR8 to process and consequently its overall function in miRNA maturation. Each chemical, through its unique mechanism, can lead to an inhibition of DGCR8's functional role in the cell.